BioSpace News Archive

Deals

AmerisourceBergen Completes Acquisition of H. D. Smith

AmerisourceBergen announced that it has completed the acquisition of H. D. Smith, the largest independent wholesaler in the U.S., for $815 million in cash, subject to a customary working capital adjustment.

January 3, 2018
·
6 min read
BioMidwest

Medical Design Engineers’ Adhesive Selection Process Made Easier With New 3M Product Selector Tool

The product selector tool will be available to demo at CES 2018 in Las Vegas from January 9-12, 2018 in the 3M booth located in Sands, Halls A-D; 43517 Health & Wellness Marketplace.

January 3, 2018
·
3 min read
Deals

NovaQuest Capital Management to Acquire Viamet Pharmaceuticals and the VT-1161 Antifungal Program

Upon closing of the acquisition, Viamet Pharmaceuticals will be a portfolio company of NovaQuest Capital, which will focus on further development of VT-1161 and related assets.

January 3, 2018
·
6 min read
Genetown

Synspira Announces $3 Million Development Award From Cystic Fibrosis Foundation

Synspira today announced that it has received up to a $3 million award from the Cystic Fibrosis (CF) Foundation to advance clinical development of its lead candidate, SNSP113, for use in pulmonary complications of cystic fibrosis (CF).

January 3, 2018
·
3 min read
Genetown

InVivo Therapeutics Announces Latest Results from INSPIRE and Provides Update on Proposed Clinical Path Forward

The primary endpoint of the study is defined as improvement in ASIA Impairment Scale (AIS) grade from baseline for all evaluable patients at the six-month visit.

January 3, 2018
·
5 min read
Business

Proclara Biosciences Strengthens Leadership Team with Appointment of David Michelson, M.D., as Chief Medical Officer

Dr. Michelson joins Proclara from Merck Research Laboratories, where he served for over a decade as Vice President and Therapeutic Area Head with responsibility for clinical research in Neuroscience, Pain, Anesthesiology and Ophthalmology.

January 3, 2018
·
3 min read
Business

Dr. Xiaoxiang Chen Joins Harbour BioMed as Executive Vice President, Head of Clinical Development and Regulatory Science

Dr. Chen brings to Harbour BioMed more than 20 years of leadership experience in regional and global clinical development, most recently as Boehringer Ingelheim’s Vice President, Regional Medical Management for Emerging Markets.

January 3, 2018
·
3 min read
Business

Boston Pharmaceuticals Appoints Dr. Peter Ho as Chief Medical Officer

Dr. Ho joins Boston Pharmaceuticals from Epizyme, where as Chief Medical Officer he led the company’s clinical development, translational medicine and regulatory affairs functions.

January 3, 2018
·
3 min read
Business

FLX Bio Appoints Dirk G. Brockstedt, Ph.D., as Senior Vice President of Biology

Dr. Brockstedt joins FLX Bio most recently from Aduro Biotech, where he served in a number of escalating positions, most recently as Executive Vice President of Research and Development.

January 3, 2018
·
3 min read
Boehringer Ingelheim Ups Venture Fund to €250M

The additional funds will be used to invest in promising early stage start-up companies, focusing on regenerative medicine, infectious diseases and immune oncology among others.

January 3, 2018
·
4 min read